2017 Regional IVD Market Bundle

  • ID: 4401780
  • Report
  • Region: Global
  • 845 Pages
  • Kalorama Information
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Biomérieux S.A.
  • DiaSorin S.p.A.
  • Hologic, Inc.
  • Nihon Kohden Corporation
  • Randox Laboratories
  • MORE

The IVD industry is constantly seeking markets where they can experience better than average growth. this report contains five separate market research studies that combine for 840 pages of market information about emerging IVD markets, including:

  • United States IVD Market (2016)
  • Brazil IVD Markets (2017)
  • Indonesia IVD Markets (2017
  • Mexico IVD Markets (2017)
  • India IVD Market (2016)

This Bundle is designed to provide cost savings to market researchers by providing several of our popular and recent reports in one package. This report, consisting of a combined PDF with five reports, each with their own TOC, provides informative analysis of each country market and company activity information. 

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Biomérieux S.A.
  • DiaSorin S.p.A.
  • Hologic, Inc.
  • Nihon Kohden Corporation
  • Randox Laboratories
  • MORE

United States IVD Market:

1: Executive Summary

  • Introduction
  • Market Metrics - Utilization
  • Market Metrics - Aging
  • Market Metrics - Disease
  • Market Metrics - U.S. Total Health and Clinical Lab Expenditures and Payers
  • Market Metrics - U.S. Clinical Testing by Channel
  • Impacts of the Affordable Care Act
  • Impacts of PAMA and LDT Reform
  • U.S. IVD Market
  • Top Tier U.S. IVD Market Participants and Rankings
  • ConclusionCR

2: Introduction to U.S. Health Care

  • The United States and In Vitro Diagnostics
  • U.S. Patient Population
  • Healthcare System Utilization
  • Aging
  • Disease Prevalence and Incidence
  • Health Insurance in the United States and the Affordable Care Act
  • U.S. Health Expenditure
  • U.S. Clinical Lab Expenditure
  • Affordable Care Act (ACA)
  • Clinical Testing under Medicare - Reimbursement Cuts and Market-Based Pricing 55
  • Protecting Access to Medicare Act of 2014 (PAMA)
  • Molecular Diagnostics and Medicare Policy
  • Laboratory-Developed Tests (LDTs) Invigorate Market, Challenge Regulators
  • U.S. Healthcare Infrastructure and Testing Channels
  • Hospitals
  • Independent Labs
  • Physician Office Laboratories
  • Self-Testing
  • Retail Clinics
  • Conclusions

3: U.S. IVD Market Analysis

  • Clinical Chemistry
  • Microbiology and Virology - ID/AST and Molecular
  • Point-of-Care Testing
  • Immunoassays
  • Urinalysis
  • Molecular Diagnostics
  • Coagulation
  • Histology
  • Hematology
  • Blood Testing and Typing
  • Flow Cytometry
  • Total U.S. IVD Market

4: Top Tier U.S. IVD Market Players

  • Abbott Diagnostics
  • Core Lab
  • Hematology
  • Molecular
  • Blood Testing
  • Mass Spectrometry ID/AST
  • Diabetes Testing
  • Point-of-Care (POC) Diagnostics
  • Alere
  • Critical Care
  • Lipids and Cardiac Markers
  • Diabetes Testing
  • Coagulation
  • Toxicology / Drugs of Abuse
  • Infectious Diseases
  • Beckman Coulter (Danaher)
  • Immunoassays
  • Clinical Chemistry
  • Hematology
  • Microbiology
  • Urinalysis
  • Flow Cytometry
  • Molecular
  • Becton, Dickinson and Company (BD)
  • Microbiology
  • Mass Spectrometry
  • Immunoassays
  • Molecular
  • Histology/Cytology
  • Flow Cytometry
  • bioMérieux
  • Microbiology
  • Mass Spectrometry
  • Immunoassays
  • Molecular
  • Sequencing
  • Bio-Rad Laboratories
  • Microbiology
  • Hemoglobinopathy and Diabetes Testing
  • Immunoassays
  • Blood Typing and Testing
  • Tissue Typing
  • Sequencing
  • Cepheid
  • Molecular Hospital-Acquired Infection (HAI) Testing
  • Molecular Sexual Health and Women’s Health Testing
  • Molecular Critical Infectious Disease Testing
  • Molecular Oncology Testing
  • Danaher Corporation
  • Histology
  • Point-of-Care Testing
  • Hologic
  • Molecular Cytology / Histology (HPV)
  • Other Molecular (STIs, HIV, HCV, TB, Respiratory)
  • Microbiology (AccuProbe Molecular Culture ID Tests)
  • Blood Testing (Molecular PROCLEIX Tests)
  • Johnson & Johnson (Incl. Janssen Diagnostics)
  • Ortho-Clinical Diagnostics
  • Core Lab
  • Blood Testing and Typing
  • QIAGEN
  • Molecular Infectious Disease
  • Companion Diagnostics
  • Immunoassays
  • Next-Generation Sequencing
  • Roche Diagnostics
  • Professional Diagnostics
  • Immunoassays
  • Point-of-Care Diagnostics
  • Diabetes Care
  • Tissue Diagnostics
  • Molecular Diagnostics
  • Blood Testing
  • Sequencing
  • Microbiology (GeneWeave)
  • Siemens Healthcare Diagnostics
  • Clinical Chemistry
  • Immunoassays
  • Hematology
  • Molecular Diagnostics and Histology
  • Urinalysis
  • Coagulation
  • Point-of-Care Diagnostics
  • Sysmex Corporation
  • Hematology
  • Coagulation
  • Urinalysis
  • Thermo Fisher Scientific
  • Immunoassays
  • Drug Testing
  • Histology
  • Mass Spectrometry
  • Microbiology
  • Molecular
  • Sequencing

Brazil IVD Markets

1: Executive Summary

  • Industry Overview
  • Scope And Methodology
  • Brazil IVD Market Summary
    • Figure 1-1: Brazil In Vitro Diagnostic Sales By Market Segment, 2016-2021 (Clinical Chemistry, Immunoassay, Microbiology, Poc, Histology, Other)

2: Brazil Overview

  • Population
    • Table 2-1: Total Midyear Population By Broad Age Group: Brazil (Million Persons), 2010-2050 (0-14, 15-64, 65+)
    • Figure 2-1: Total Midyear Population By Broad Age Group: Brazil (Million Persons), 2010-2050 (0-14, 15-64, 65+)
    • Figure 2-2: Total Number Of Births In Brazil By Year, 1970-2010, And Forecast 2020-2050
    • Figure 2-3: Brazil Life Expectancy At Birth In Years, 2010-2050
  • Population Urbanization
  • Economy And Health Spending
    • Figure 2-4: Brazil Gdp, Gdp (Ppp) And Health Spending, 1990-2015
    • Figure 2-5: Brazil Distribution Of Income Or Consumption By Quintile, 1990-2014

3: The Health System In Brazil

  • Health Infrastructure
    • Figure 3-1: Brazilian Coverage Rate (%) For Private Health Plans And Public Health Plans, 2003-2015 (Private Medical Aid Plan Beneficiaries With Or Without Dental Care, Public Health Plan Beneficiaries)
    • Figure 3-2: Health Expenditures, Public Vs. Private As A % Of Total Health Expenditures, 2015 (Private, Public)
  • Medical Facilities
    • Figure 3-3: Distribution Of Jci Accredited Facilities By Metropolitan Area (%) (Sao Paulo, Rio De Janeiro, Recife, Brasilia, Porto Alegre, Others)
    • Figure 3-4: Distribution Of Jci Accredited Facilities By Type (%) (Hospital Program, Academic Medical Center, Ambulatory Care, Home Care, Medical Transport, Primary Care)
    • Figure 3-5: Hospital Bed Density Per 1,000 Population By Country, 2016 Estimates (Us, Uk, Singapore, Japan, Germany, China, Canada, Brazil, Australia)
  • Physicians And Health Professionals
    • Figure 3-6: Physician Density Per 1,000 Population By Country, 2016 Estimates (Us, Uk, Singapore, Japan, Germany, China, Canada, Brazil, Australia)
    • Figure 3-7: Nurse/Midwife Density Per 1,000 Population By Country, 2016 Estimates (Us, Uk, Singapore, Japan, Germany, China, Canada, Brazil, Australia)
  • The Brazilian Diagnostic Laboratory Environment
    • Figure 3-8: Laboratories And Collection Sites In Brazil By Type (%), 2016 (Collection Sites, All Types; Commercial Laboratories; Hospital-Based Laboratories)
    • Figure 3-9: Distribution Of Volume, Brazil's Leading Clinical Laboratory Service Providers (%), 2016
  • Medical Device Regulation
    • Table 3-1: Market Divers And Inhibitors For Entering Brazil's Medical Device Market
    • Figure 3-10: Market Entry Complexity For Foreign Operators In Brazil
  • Brazil's Growing Medical Tourism Industry
  • Health Indicators
  • General Health
  • Disease Profiles In Brazil
    • Table 3-2: Top 5 Cancers Affecting Brazilian Population (Ranked By Total Number Of Cases), 2010-2016 (Male, Female, Total [Both Sexes])
    • Figure 3-11: Highly Prevalent Medical Conditions/Diseases In Brazil (Zika Virus, Tuberculosis, Malaria, Leprosy, Hiv, Diabetes, Dengue, Chagas Disease, Cardiovascular Diseases, Cancer)
  • Surgical Procedures In Brazil
  • Table 3-3: Surgical Procedures In Brazil As Compared To Rest Of Latin America (%) (Cardiovascular Procedures, Digestive/Gastrointestinal Procedures, Obstetrical/Gynecological Procedures, Orthopedic Procedures, Ent/Respiratory Procedures, Urinary Surgical Procedures, Cosmetic/Aesthetic Procedures, Other Procedures, Total)
    • Figure 3-12: Brazil, Mexico And Rest Of Latam Distribution Of Population Compared To Surgical Procedures (%)

4: IVD Markets In Brazil

  • Brazil IVD Market Summary
    • Table 4-1: Brazil In Vitro Diagnostic Sales By Market Segment, 2016-2021 (Clinical Chemistry, Immunoassay, Microbiology/Molecular, Poc, Histology, Other, Total)
    • Figure 4-1: Brazil In Vitro Diagnostic Sales By Market Segment, 2016-2021 (Clinical Chemistry, Immunoassay, Microbiology, Poc, Histology, Other)
    • Figure 4-2: Brazil In Vitro Diagnostic Sales By Market Segment, 2016 Market Distribution (%) (Clinical Chemistry, Immunoassays, Microbiology/Molecular, Poc, Histology, Other)
  • Clinical Chemistry
    • Figure 4-3: Brazil - Clinical Chemistry Market, 2016-2021
  • Immunoassay
    • Table 4-2: Brazil - Immunoassay Market Distribution, 2016-2021 (%) (Infectious Disease, Other, Total Immunoassay)
    • Figure 4-4: Brazil - Immunoassay Market Value By Segment, 2016 Vs. 2021 (Infectious Disease, Other)
  • Microbiology/Molecular
    • Table 4-3: Brazil - Microbiology/Molecular Testing Market Distribution, 2016-2021 (%) (Infectious Disease, Other, Total Microbiology/Molecular Testing)
    • Figure 4-5: Brazil Microbiology/Molecular Testing Market Value By Segment, 2016 Vs. 2021 (Infectious Disease, Other)
  • Point-Of-Care
    • Table 4-4: Brazil - Poc Market Distribution, 2016-2021 (%) (Poc Glucose, Poc Infectious Disease, Poc Other, Total Poc)
    • Figure 4-6: Brazil Poc Market Value By Segment, 2016 Vs. 2021 (Poc Glucose, Poc Infectious Disease, Others)
  • Histology
    • Figure 4-7: Brazil - Histology Market, 2016-2021

5: Competitive Analysis And Profiles

  • Competitive Summary
    • Table 5-1: Leading Ivd Market Suppliers In Brazil, Market Share Percentage, 2016
    • Figure 5-1: Leading Ivd Market Suppliers In Brazil, 2016 (%)
  • Abbott Laboratories
    • Table 5-2: Abbott Laboratories Company Summary
    • Company Overview
    • Company Performance
    • Product Summary
  • Alere
    • Table 5-3: Alere Company Summary
    • Company Overview
    • Performance Review
    • Product Summary
  • Becton, Dickinson And Company
    • Table 5-4: Becton, Dickinson And Company Summary
    • Company Overview
    • Company Performance
    • Product Summary
  • Biomérieux Sa
    • Table 5-5: Biomerieux Summary
    • Company Overview
    • Company Performance
    • Product Summary
  • Danaher Corporation
    • Table 5-6: Danaher Corporation Summary
    • Company Overview
    • Company Performance
    • Product Summary
  • Roche (F. Hoffman-La Roche, Ltd.)
    • Table 5-7: Roche Group Summary
    • Company Overview
    • Company Performance
    • Product Summary
  • Siemens Healthineers
    • Table 5-8: Siemens Healthineers Company Summary
    • Company Overview
    • Company Performance
    • Product Summary
  • Sysmex Corporation
    • Table 5-9: Sysmex Corporation Summary
    • Company Overview
    • Company Performance
    • Product Summary

Indonesia IVD Market:

1: Executive Summary
  • Introduction
    • Figure 1-1: Map of Indonesia, with Provinces
    • Figure 1-2: Total Population of Indonesia (2000-2016)
    • Table 1-1: GDP Growth in Indonesia, 2012-2015
  • Health Status Of Indonesians
  • Healthcare Delivery System
  • Regulation Of Ivd Devices And Distribution
  • Scope And Methodology
  • Size And Growth Of The Ivd Market
    • Figure 1-3: IVD Market in Indonesia, 2017 and 2022

2: Indonesia - A Growing IVD Market

  • Healthcare Expenditure In Indonesia
    • Figure 2-1: Growth of Health Expenditure per Capita (USD) in Indonesia, 2000-2014
    • Figure 2-2: Growth of Health Expenditure per Capita in PPP Terms (USD), Indonesia, 2000-2014
    • Health Indicators In Indonesia
    • Figure 2-3: Top 10 Causes of Death in Indonesia
    • Table 2-1: Life Expectancy and Mortality Rates in Indonesia, 2000-2014 (Life Expectancy, Total; Life Expectancy at Birth, Male; Life Expectancy at Birth, Female; Total Mortality Rate, Adult, Male; Total Mortality Rate, Adult, Female)
    • Prevalent Infectious Diseases In Indonesia
    • Tuberculosis (TB)
    • Table 2-2: Assessment of TB Burden in Indonesia, WHO
    • Table 2-3: Pulmonary Tuberculosis Cases by Province, Indonesia
    • HIV/AIDS
    • Table 2-4: The Number of New Cases of HIV and AIDS between 2011 and 2015, Indonesia
    • Table 2-5: HIV and AIDS Cases in Indonesia, by Province
    • Malaria
    • Table 2-6: Incidence of Malaria in Indonesia, by Province
    • Dengue
    • Table 2-7: Dengue Hemorrhagic Fever (DHF) Cases in Indonesia, by Province
    • Filariasis
    • Table 2-8: Filariasis in Indonesia, 2011-2015
    • Table 2-9: Filariasis Cases in Indonesia, by Province, 2012-2014
    • Leptospirosis
    • Table 2-10: Leptospirosis Cases in Indonesia, by Province, 2011-2015
    • Typhoid
    • Table 2-11: Typhoid Prevalence in Indonesia, by Province
    • Human Papilloma Virus (HPV)
  • Indonesian Healthcare Industry Landscape
    • Figure 2-4: Healthcare Delivery in Indonesia
    • Healthcare Delivery System
    • Public Healthcare System: General and Specialty Hospitals
    • Table 2-12: General and Specialty Hospitals in Indonesia, 2011-2015
    • Public Healthcare System: Community Healthcare Centers (CHCs/Puskesmas)
    • Table 2-13: Community Healthcare Centers in Indonesia, 2011-2015
    • Table 2- 14: Distribution of Puskesmas (CHCs) in Indonesia across 34 Provinces
    • Hospital Classification in Indonesia
    • Table 2-15: Selected General and Specialty Hospitals in Indonesia
    • Private Healthcare System
    • Table 2-16: Selected Leading
    • Private Hospitals in Indonesia, by Province
    • Private Labs in Indonesia
    • Table 2-17: Selected Private Laboratories in Indonesia
  • Financial Aspects Of The Healthcare Industry In Indonesia
    • Table 2-18: Indonesia Healthcare Spending Compared to Southeast Asia Neighbors (New Zealand, Japan, Australia, South Korea,
    • Vietnam, China, Singapore, India, Malaysia, Thailand)
    • Table 2-19: Indonesia Healthcare Expenditure, 2000-2014 (Total Health Expenditure as % of GDP, Public Health Expenditure, Private Health Expenditure)
    • Implementation of UHC
    • Private Health Insurance
    • E-Catalogue Pricing System
    • Key Market Drivers Of The Indonesian Healthcare Market
  • Key Challenges In The Indonesian Healthcare Market
    • Uncertainty among Private Insurers
    • Rigid Reference Model Hampering Healthcare Accessibility
    • Limited Access to Quality Healthcare Facilities
    • Gap between Supply and Demand of Medical Professionals
    • Impact of the E-Catalogue Pricing System
    • Impact of Government’s Policies on Foreign Direct Investments (FDI)
    • Logistics Challenges
  • IVD Product Regulation In Indonesia
    • Table 2-20: Classification of Medical Devices
  • Important Factors To Consider While Choosing An Ivd Distributor In Indonesia
    • Trade-Off between Small and Big Distributors
    • Table 2-21: Selected Foreign Companies and Their Key Distributors in Indonesia
  • Processes For Distribution License, Company And Product Registrations
    • Company/Product Registration
    • Table 2-22: Licenses Required for IVD Distribution in Indonesia
  • Regulatory Trends And Insights Relevant For The IVD Sector
    • Market Transition to E-Catalogue and Related Regulations
    • Regulations For Foreign Direct Investments (FDI)
    • Table 2-23: Indonesia Investment Coordinating Board (BKPM) Offices
  • Setting Up A Company In Indonesia
    • Table 2-24: Options for a Foreign IVD Company to Enter the Indonesian Market
    • Assessing Option 1: Opening an Affiliated Branch Office in Indonesia
    • Assessing Option 2: Select a Suitable Exclusive Distributor
    • Assessing Option 3: Set up OEM Operations; Invest in Local Manufacturing within 3 years
  • Business Strategies Adopted By Multinational Companies (Mncs): Case Studies
    • Roche
    • bioMerieux
    • Thermo Fisher Scientific
    • Conclusion

3: IVD Market Analysis

  • Microbiology
  • LFIA Tests (Rapid Tests) for Infectious Diseases
    • Table 3-1: Sales of Rapid Tests for Infectious Diseases by Category, Indonesia, 2017-2022 (HIV; STDs; Hepatitis [HBV, HCV, etc.]; Other [includes Dengue, Malaria, Typhoid, RSV, Filariasis, etc.]; Rapid Tests-Infectious Diseases, Total)
    • Table 3-2: Popular Rapid Test Brands and Their Distributors in Indonesia
  • Lab-based Immunoassays for Infectious Diseases
    • Table 3-3: STD Test Costs at Selected Clinics and Hospitals in Indonesia
    • Table 3-4: Major Diseases and Demand for Lab-based Immunoassay Diagnostics in Indonesia, 2017-2022 (HIV; STDs; Hepatitis [HBV, HCV, etc.]; Other [includes Dengue, Malaria, Typhoid, RSV, Filariasis, etc.]; Lab-based Immunoassays - Infectious Diseases, Total) ID/AST
  • Molecular Diagnostics
    • Table 3-5: Microbiology Sales in Indonesia, 2017-2022 (Rapid Tests-Infectious Diseases; Lab-based Immunoassays - Infectious Diseases; Molecular Diagnostics - Microbiology; Other [includes supplies, reagents, etc.]; Microbiology, Total)
  • Hematology
    • Table 3-6: List of Major Players in the Indonesian Hematology Market
    • Table 3-7: Hematology Sales by Category, Indonesia, 2017-2022 (Hematology Systems; Hematology POC; Other [Digital imaging, analysis software, etc.]; Hematology, Total)
  • Clinical Chemistry
    • Table 3-8: List of Major Players in the Indonesian Clinical Chemistry Market
    • Table 3-9: Clinical Chemistry Analyzer Sales by Category, Indonesia, 2017-2022 (General Chemistry; Blood Gas Analyzers; Critical Care POC; Clinical Chemistry, Total)
  • Point-Of-Care Tests
  • POC - OTC/ Self-Testing
  • POC - Professional-Testing
  • POC Hand-Held Devices
  • POC Bench-Top Analyzers
    • Table 3-10: POC Sales by Category, Indonesia, 2017-2022 (POC-Diabetes; POC-OTC/Self-Testing, Other; POC-OTC/Self Testing, Total; Cardiac Markers; DOA/Toxicology; Other; POC-Professional, Total; POC, Total)
  • Immunoassays
  • Point-of-Care (POC) Immunoassays
  • Immunoassays for Non-Infectious Diseases
    • Table 3-11: Immunoassay (Non-Infectious) Sales by Category, Indonesia, 2017-2022 (Diabetes; Cardiac markers; Other [Cancer Markers, DOA tests; cholesterol, RIAs for thyroid, hormones, endocrine markers, etc.]; Total, Lab-based Immunoassays - Non-Infectious; DOA testing - rapid tests; Cancer markers - Rapid tests; Cardiac markers - Rapid tests; Others [Pregnancy, Cancer markers, etc.]; Total, POC - Immunoassays - Non-Infectious; Total - Immunoassays - Non-Infectious)
  • Blood Testing And Typing
    • Table 3-12: Distribution of Blood Centers in Indonesia, by Province
  • Non-Standardized Evaluation Protocol
    • Table 3-13: Blood Testing and Typing Sales by Category (ABO Grouping, Immunoassays [ELISA and Rapid Tests], NAT), Indonesia, 2017-2022
  • Urinalysis
    • Table 3-14: List of Major Players in the Indonesian Urinalysis Market
  • Coagulation
    • Table 3-15: List of Major Players in the Indonesian Coagulation Market
    • Table 3-16: Hemostasis Sales by Category (Lab-based Coagulation Tests, POC Coagulation Tests), Indonesia, 2017-2022
  • Histology
    • Table 3-17: List of Major Players in the Indonesian Histology Market
    • Table 3-18: Histology Sales by Category (Traditional Non-Pap Stains, Pap Tests, HPV, Other [includes ISH, IHC, Digital Imaging, CTC, and Flow Cytometry]), Indonesia, 2017-2022
  • Total IVD Markets In Indonesia
    • Table 3-19: Total IVD Market in Indonesia by Segment (Microbiology, Hematology, Clinical Chemistry, POC, Immunoassays - Non-Infectious Diseases, Blood Testing and Typing, Urinalysis, Coagulation, Histology, Others [includes Molecular Diagnostics (Non-Infectious), Supplies, Reagents, IT, Imaging, Automation, etc.]), 2017-2022

4: IVD Companies, Private Labs And Distributor Profiles

  • IVD Company Profiles
    • Abbott Laboratories
    • Alere
    • Arkray Healthcare
    • Beckman Coulter
    • Becton, Dickinson and Company (BD)
    • bioMerieux
    • Bio-Rad
    • Cellavision
    • Cepheid
    • Critical Diagnostics
    • DiaSorin S.p.A.
    • EKF Diagnostics
    • ERBA Diagnostics
    • HemoCue AB
    • Hologic, Inc.
    • Horiba, Ltd.
    • Instrumentation Laboratory Company
    • Luminex Corporation
    • Mindray Medical International Limited
    • Nihon Kohden Corporation
    • Ortho Clinical Diagnostics
    • Qiagen N.V.
    • Radiometer Medical ApS
    • Randox Laboratories
    • Roche Diagnostics
    • Siemens Healthineers
    • Sysmex Corporation
    • Thermo Fisher Scientific
    • Tosoh Corporation
    • Trinity Biotech
  • Leading Private Labs In Indonesia
    • Laboratorium Klinik Utama Bio Medika
    • PT Cito Putra Utama
    • PT Kimia Farma Diagnostika
    • Laboratorium Klinik Pramita
    • PT Prodia Widyahusada Tbk
    • Profiles Of Selected Ivd Distributors In Indonesia
    • Table 4-1: Profiles of Selected IVD Distributors in Indonesia

Mexico IVD Market:

1: Executive Summary

  • Industry Overview
  • Scope And Methodology
  • Mexico IVD Market Summary
    • Figure 1-1: Mexico In Vitro Diagnostic Sales by Market Segment, 2016-2021 (Clinical Chemistry, Immunoassay Infectious Disease, Immunoassay Other, Microbiology/Molecular, POC Glucose, POC Other, Histology, Other)

2: Mexico Overview

  • Population
    • Table 2-1: Total Midyear Population by Broad Age Group: Mexico (million persons), 2010-2050 (0-14, 15-64, 65+, Total Population)
    • Figure 2-1: Total Midyear Population by Broad Age Group: Mexico (million persons), 2010-2050 (0-14, 15-64, 65+)
    • Figure 2-2: Total Number of Births in Mexico by Year, 1980-2010 and Forecast 2020-2050
    • Figure 2-3: Mexico Life Expectancy at Birth in Years, 2010-2050
  • Population Urbanization
  • Economy And Health Spending
    • Figure 2-4: Mexico GDP, GDP (PPP) and Health Spending, 1990-2015
    • Figure 2-5: Mexico Distribution of Income or Consumption by Quintile, 1990-2014 (Income share held by highest 20%, Income share held by fourth 20%, Income share held by third 20%, Income share held by second 20%, Income share held by lowest 20%)

3: The Health System In Mexico

  • Health Infrastructure
    • Figure 3-1: Health Expenditures, Public vs. Private, as a % of Total Health Expenditures, 2015
  • Medical Facilities
    • Figure 3-2: Distribution of JCI Accredited Facilities by Metropolitan Area (Culiacan, Tijuana, Cancun, Chihuahua, Mexico City)
    • Figure 3-3: Distribution of JCI Accredited Facilities by Type (%; Hospital Program, Ambulatory Care)
    • Figure 3-4: Distribution of JCI Accredited Facilities by Length of Time from First Accreditation (Withdrawn/Expired, 5+ Years, 2-5 Years, Less Than 2 Years)
    • Figure 3-5: Hospital Bed Density per 1,000 Population by Country,2016 Estimates (United States, UnitedKingdom, Singapore, Mexico, Japan, Germany, China, Canada, Brazil, Australia) Physicians and Health Professionals
    • Figure 3-6: Physician Density per 1,000 Population by Country, 2016 Estimates (United States, United Kingdom, Singapore, Mexico, Japan, Germany, China, Canada, Brazil, Australia)
    • Figure 3-7: Nurse/Midwife Density per 1,000 Population by Country, 2016 Estimates (United States,United Kingdom, Singapore, Mexico, Japan, Germany, China, Canada, Brazil, Australia)
  • The Mexican Diagnostic Laboratory Environment
    • Figure 3-8: Laboratories and Collection Sites in Mexico by Type, 2016 (%; Commercial Laboratories,Collection Sites/Patient Service Centers)
    • Figure 3-9: Distribution of Volume, Mexico's Leading Clinical Laboratory Service Providers, 2016 (%) Medical Device Regulation
    • Table 3-1: Market Drivers and Inhibitors for Entering Mexico's Medical Device Market Mexico's Growing Medical Tourism Industry
  • Health Indicators
  • General Health
  • Disease Profiles in Mexico
    • Table 3-2: Top 5 Cancers Affecting Mexican Population (ranked by total number of cases), 2010-2016
    • Figure 3-10: Medical Conditions/Diseases Prevalence in Mexico (Tuberculosis, Malaria, HIV, Diabetes,Dengue, Cardiovascular Diseases, Cancer)

4: IVD Markets In Mexico

  • Mexico IVD Market Summary
    • Table 4-1: Mexico In Vitro Diagnostic Sales by Market Segment, 2016-2021 (Clinical Chemistry,Immunoassay Infectious Disease, Immunoassay Other, Microbiology/Molecular, POC Glucose, POC Other, Histology, Other, Total)
    • Figure 4-1: Mexico In Vitro Diagnostic Sales by Market Segment, 2016-2021 (Clinical Chemistry, Immunoassay Infectious Disease, Immunoassay Other, Microbiology/Molecular, POC Glucose, POC Other, Histology, Other)
    • Figure 4-2: Mexico In Vitro Diagnostic Sales by Market Segment, 2016 Market Distribution (%) (Clinical Chemistry, Immunoassay Infectious Disease, Immunoassay Other, Microbiology/Molecular, POC GlucosePOC Other, Histology, Other)
  • Clinical Chemistry
    • Figure 4-3: Mexico - Clinical Chemistry Market, 2016-2021
  • Immunoassay
    • Table 4-2: Mexico - Immunoassay Market Distribution, 2016-2021 (%) (Infectious Disease, Other, Total Immunoassay)
    • Figure 4-4: Mexico - Immunoassay Market Value by Segment, 2016 vs. 2021 (Infectious Disease, Other)
  • Microbiology/Molecular
    • Table 4-3: Mexico - Microbiology/Molecular Testing Market Distribution, 2016-2021 (%) (Infectious Disease, Other, Total Microbiology/Molecular Testing)
    • Figure 4-5: Mexico Microbiology/Molecular Testing Market Value by Segment, 2016 vs. 2021 (Infectious Disease, Other)
  • Point-Of-Care
    • Table 4-4: Mexico - POC Market Distribution, 2016-2021 (%) (POC Glucose, POC Other, Total POC)
    • Figure 4-6: Mexico POC Market Value by Segment, 2016 vs. 2021 (POC Glucose, POC Other)
  • Histology
    • Figure 4-7: Mexico - Histology Market, 2016-2021

5: Competitive Analysis And Profiles

  • Competitive Summary
    • Table 5-1: Leading IVD Market Suppliers in Mexico, Market Share Percentage, 2016
    • Figure 5-1: Leading IVD Market Suppliers in Mexico, 2016 (%)
  • Abbott Laboratories
    • Table 5-2: Abbott Laboratories Company Summary
  • Company Overview
  • Company Performance
  • Product Summary
  • Becton, Dickinson And Company
    • Table 5-3: Becton, Dickinson and Company Summary
  • Company Overview
  • Company Performance
  • Product Summary
  • Biomérieux S.A.
    • Table 5-4: bioMerieux Summary
  • Company Overview
  • Company Performance
  • Product Summary
  • Danaher
    • Table 5-5: Danaher Summary
  • Company Overview
  • Company Performance
  • Product Summary
  • Diasorin S.P.A.
    • Table 5-6: DiaSorin S.p.A. Summary
  • Company Overview
  • Company Performance
  • Product Summary
  • Lifescan, Inc
    • Table 5-7: LifeScan Summary
  • Company Overview
  • Company Performance
  • Product Summary
  • Roche (F. Hoffman-La Roche, Ltd.)
    • Table 5-8: Roche Group Summary
  • Company Overview
  • Company Performance
  • Product Summary
  • Siemens Healthineers
    • Table 5-9: Siemens Healthineers Company Summary
  • Company Overview
  • Company Performance
  • Product Summary
  • Sysmex Corporation
    • Table 5-10: Sysmex Corporation Summary
  • Company Overview
  • Company Performance
  • Product Summary
  • Thermo Fisher Scientific
    • Table 5-11: Thermo Fisher Summary
  • Company Overview
  • Company Performance
  • Product Summary
  • Appendix: Sources Of Information

India IVD Market:

  • 1: Executive Summary
  • Introduction
  • Scope and Methodology
  • Major Findings of the Report
  • India in Context - A Rapidly Developing Economy with Major Demographic
  • Challenges
  • Demographic Aging
  • Disease Drivers
  • Infectious Disease Threats
  • Indian Economy
  • IVD Market in the BRIC Countries
  • IVD Market in India
  • SWOT Analysis
  • Leading Players

2: Introduction To Health Care And Diagnostics In The Developing World - India In Context

  • Background
  • Population Trends and Disease Demographics
  • Obesity
  • Disease Trends
  • Diabetes
  • Cancer
  • Allergy and Asthma
  • Cardiovascular Disease
  • Emerging Viruses and Diseases
  • Antimicrobial Drug Resistance
  • Clinical Lab Tests
  • Types of Tests
  • Venues for Test Usage
  • Market Segment Opportunities
  • Point-of-Care (POC) Testing
  • Core Lab Tests
  • Molecular Assays
  • Hematology
  • Coagulation
  • Microbiology
  • Tests Used in Blood Banking
  • Histology and Cytology
  • The Future of Indian Economic Growth
  • Rising Standards of Living
  • Young, English-Speaking Labor Force
  • Corruption and Bribery
  • Exchange Rate
  • BRIC Metrics - Indian IVD Market in Context
  • Available Markets - Urban Populations in BRIC Countries
  • Paying for Healthcare - Government Expenditures and the Culture of Spending
  • Healthcare Capacities in BRIC Nations - A Work in Progress
  • IVD Spending

3: India IVD SWOT Analysis

  • Introduction
  • Strengths - Conditions That Support Market Growth
  • Government Support of the Emerging Indian Healthcare Market
  • Expanding Medical Education
  • Increasing Health Insurance Penetration
  • Improving Intellectual Property Protection
  • Thriving Biotech Industry
  • Contract Research and High Technology
  • Returning Scientists
  • Growing Hospital Sector
  • Expanding Clinical Labs
  • Medical Tourism
  • Strong IT Sector
  • Weaknesses - Factors That Pose Barriers to Market Success and Entry
  • Traditional Medicine
  • Resource Constraints in Hospitals
  • Culture and Business Environment
  • Quality and Safety Concerns
  • Lack of Medical Device and Diagnostics Regulation
  • Lack of IVD R&D
  • High Out of Pocket Consumer Expenditures
  • Healthcare Pricing
  • Opportunities - Rural Healthcare and Technology Partnerships
  • Threats - Domestic and Chinese Competition
  • Domestic Competition
  • Chinese Competition

4: India IVD Market Size

  • Introduction
  • The Market
  • Total Indian IVD Market
  • Immunoassays
  • Clinical Chemistry
  • Hematology
  • Point of Care/OTC
  • Molecular
  • Urinalysis
  • Other IVD Tests

5: Industry And Company Activity In India

  • Introduction
  • Market Leaders in India
  • Indian IVD Players
  • International IVD Companies - Recent Activity
  • Abbott Laboratories
  • Affymetrix, Inc.
  • Alere
  • Arkray
  • Beckman Coulter, Inc./Danaher
  • Becton, Dickinson & Co
  • Biohit Oy
  • bioMérieux, Inc.
  • Bio-RAD Laboratories, Inc.
  • Daan Gene Co., Ltd.
  • Danaher Corp.
  • Gen-Probe, Inc.
  • Grifols
  • Hologic, Inc.
  • Horiba Medical
  • Instrumentation Laboratory
  • Laboratory Corporation of America
  • Luminex Corporation
  • MedMira
  • Mindray Medical International, Ltd.
  • Myriad Genetics
  • Ortho Clinical Diagnostics
  • PerkinElmer
  • Promega Corporation
  • QIAGEN N.V.
  • Quest Diagnostics
  • Radiometer A/S
  • Roche
  • Shanghai Fosun Pharmaceutical Co. Ltd.
  • Shanghai Kehua Bio-engineering
  • Siemens
  • SRL Diagnostics
  • Sysmex Corp.
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories
  • Affymetrix, Inc.
  • Alere
  • Arkray Healthcare
  • Beckman Coulter, Inc./Danaher
  • Becton, Dickinson & Co
  • Bio-RAD Laboratories, Inc.
  • Biohit Oy
  • Biomérieux S.A.
  • Cellavision
  • Cepheid
  • Critical Diagnostics
  • Daan Gene Co., Ltd.
  • Danaher Corporation
  • DiaSorin S.p.A.
  • EKF Diagnostics
  • ERBA Diagnostics
  • Gen-Probe, Inc.
  • Grifols
  • HemoCue AB
  • Hologic, Inc.
  • Horiba, Ltd.
  • Instrumentation Laboratory Company
  • Laboratory Corporation of America
  • Lifescan, Inc
  • Luminex Corporation
  • MedMira
  • Mindray Medical International, Ltd.
  • Myriad Genetics
  • Nihon Kohden Corporation
  • Ortho Clinical Diagnostics
  • PerkinElmer
  • Promega Corporation
  • Qiagen N.V.
  • Quest Diagnostics
  • Radiometer Medical ApS
  • Randox Laboratories
  • Roche Diagnostics
  • SRL Diagnostics
  • Shanghai Fosun Pharmaceutical Co. Ltd.
  • Shanghai Kehua Bio-engineering
  • Siemens
  • Sysmex Corporation
  • Thermo Fisher Scientific
  • Tosoh Corporation
  • Trinity Biotech
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll